BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31838771)

  • 1. The Warburg effect and tumour immune microenvironment in extramammary Paget's disease: overexpression of lactate dehydrogenase A correlates with immune resistance.
    Urata K; Kajihara I; Miyauchi H; Mijiddorj T; Otsuka-Maeda S; Sakamoto R; Sawamura S; Kanemaru H; Kanazawa-Yamada S; Makino K; Aoi J; Makino T; Fukushima S; Komohara Y; Ihn H
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1715-1721. PubMed ID: 31838771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Existence of Staphylococcus aureus correlates with the progression of extramammary Paget's disease: potential involvement of interleukin-17 and M2-like macrophage polarization.
    Sakamoto R; Kajihara I; Mijiddorj T; Otsuka-Maeda S; Sawamura S; Nishimura Y; Kanemaru H; Kanazawa-Yamada S; Nakamura K; Honda N; Makino K; Aoi J; Igata T; Makino T; Masuguchi S; Fukushima S; Morinaga J; Komohara Y; Ihn H
    Eur J Dermatol; 2021 Feb; 31(1):48-54. PubMed ID: 33586656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Foxp3+ regulatory T cells and CD163+ macrophages in invasive and non-invasive extramammary Paget's disease.
    Fujimura T; Kambayashi Y; Hidaka T; Hashimoto A; Haga T; Aiba S
    Acta Derm Venereol; 2012 Nov; 92(6):625-8. PubMed ID: 22949100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget's disease.
    Mai R; Zhou S; Zhou S; Zhong W; Hong L; Wang Y; Lu S; Pan J; Huang Y; Su M; Crawford R; Zhou Y; Zhang G
    Hum Pathol; 2018 Jul; 77():152-158. PubMed ID: 29630912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of heat shock protein 90 through the downregulation of miR-9-5p in extramammary Paget's disease.
    Ohnuma T; Mijiddorj MT; Kajihara I; Sawamura S; Sakamoto R; Maeda-Otsuka S; Yamada-Kanazawa S; Makino K; Aoi J; Masuguchi S; Fukushima S
    J Dermatol; 2023 Sep; 50(9):1216-1221. PubMed ID: 37208828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Expression of Lactate Dehydrogenase A is a Potential Promoter of Malignant Behaviour in Extramammary Paget's Disease.
    Ogawa K; Shimada K; Takai T; Mitsui Y; Kuwahara M; Asada H
    Acta Derm Venereol; 2021 Jan; 101(1):adv00379. PubMed ID: 33470415
    [No Abstract]   [Full Text] [Related]  

  • 7. Intratumor dihydropyrimidine dehydrogenase mRNA expression levels are decreased in extramammary Paget's disease.
    Nakamura Y; Kajihara I; Yamada-Kanazawa S; Maeda-Otsuka S; Johno T; Aoi J; Igata T; Masuguchi S; Fukushima S; Jinnin M; Ihn H
    Drug Discov Ther; 2017 Jul; 11(3):152-155. PubMed ID: 28603180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
    Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK
    Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome sequencing reveals a lncRNA-mRNA interaction network in extramammary Paget's disease.
    Zheng DC; Shen YT; Wei ZW; Wan X; Xie MK; Yao HJ; Wang Z
    BMC Med Genomics; 2021 Dec; 14(1):291. PubMed ID: 34895219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed Death-Ligand 1 and Programmed Death-Ligand 2 Expression Can Affect Prognosis in Extramammary Paget's Disease.
    Kawaguchi A; Akiba J; Kondo R; Sadashima E; Ogasawara S; Naito Y; Kusano H; Sanada S; Muto I; Nakama T; Yano H
    Anticancer Res; 2021 Jan; 41(1):219-226. PubMed ID: 33419816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease.
    Chen S; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu Y; Furue M
    Clin Exp Dermatol; 2008 Aug; 33(5):634-40. PubMed ID: 18627398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-31 is distinctively overexpressed in primary male extramammary Paget's disease.
    Guo H; Qi RQ; Lv YN; Wang HX; Hong YX; Zheng S; Li JH; Gao XH; Chen HD
    Oncotarget; 2016 Apr; 7(17):24559-63. PubMed ID: 27016415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the methods used to detect HER2-positive advanced extramammary Paget's disease.
    Hirai I; Tanese K; Nakamura Y; Otsuka A; Fujisawa Y; Yamamoto Y; Hata H; Fujimura T; Matsushita S; Yoshino K; Kameyama K; Amagai M; Funakoshi T
    Med Oncol; 2018 May; 35(6):92. PubMed ID: 29744813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary and Extramammary Paget's Disease Presented Different Expression Pattern of Steroid Hormone Receptors.
    Zhou S; Zhong W; Mai R; Zhang G
    Biomed Res Int; 2017; 2017():3768247. PubMed ID: 29082243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-155, a potential serum marker of extramammary Paget's disease.
    Guo H; Qi RQ; Sheng J; Liu C; Ma H; Wang HX; Li JH; Gao XH; Wan YS; Chen HD
    BMC Cancer; 2018 Nov; 18(1):1078. PubMed ID: 30458743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIG7/LITAF gene mutation and overexpression of its gene product in extramammary Paget's disease.
    Matsumura Y; Matsumura Y; Nishigori C; Horio T; Miyachi Y
    Int J Cancer; 2004 Aug; 111(2):218-23. PubMed ID: 15197774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammary and extramammary Paget's disease: expression of Ca 15-3, Ka-93, Ca 19-9 and CD44 in Paget cells and adjacent normal skin.
    Tsuji T
    Br J Dermatol; 1995 Jan; 132(1):7-13. PubMed ID: 7538778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole genome methylation sequencing reveals epigenetic landscape and abnormal expression of FABP5 in extramammary Paget's disease.
    Kang Z; Jiang L; Chen D; Yan G; Zhang G; Lai Y; Zeng Q; Wang X
    Skin Res Technol; 2023 Oct; 29(10):e13497. PubMed ID: 37881057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic landscape of circulating tumour DNA in metastatic extramammary Paget's disease.
    Sawamura S; Mijiddorj Myangat T; Kajihara I; Tanaka K; Ide M; Sakamoto R; Otsuka-Maeda S; Kanemaru H; Nishimura Y; Kanazawa-Yamada S; Kashiwada-Nakamura K; Honda N; Makino K; Aoi J; Igata T; Makino T; Masuguchi S; Fukushima S; Ihn H
    Exp Dermatol; 2022 Mar; 31(3):341-348. PubMed ID: 34676917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential use of bisphosphonates in invasive extramammary Paget's disease: an immunohistochemical Investigation.
    Fujimura T; Furudate S; Kambayashi Y; Aiba S
    Clin Dev Immunol; 2013; 2013():164982. PubMed ID: 23606867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.